Quercetin as a therapeutic agent activate the Nrf2/Keap1 pathway to alleviate lung ischemia-reperfusion injury
Lung ischemia-reperfusion injury (LIRI) causes oxidative stress, inflammation, and immune system activation. The Nrf2/Keap1/HO-1 pathway is important in cellular defense against these effects. Quercetin, a flavonoid with antioxidant, anti-inflammatory, and anti-cancer properties, has been investigated. Our aim in this study was to investigate the effect of quercetin on preventing lung ischemia-reperfusion injury and the role of the Nrf2/Keap1/HO-1 pathway. Sixty-four male Wistar rats were divided into four distinct groups(n = 16). Sham, lung ischemia-reperfusion (LIR), Saline + LIR, Quercetin + LIR (30 mg/kg i.p for a week before LIR). LIR groups were subjected to 60 min of ischemia (left pulmonary artery, vein, and bronchus) and 120 min of reperfusion. Our assessment encompassed a comprehensive analysis of various factors, including the evaluation of expression Nrf2, Keap1, and Heme Oxygenase-1 (HO-1) levels and NF-κB protein. Furthermore, we examined markers related to inflammation (interleukin-1β and tumor necrosis factor alpha), oxidative stress (malondialdehyde, total oxidant status, superoxide dismutase, glutathione peroxidase, total antioxidant capacity), lung edema (Wet/dry lung weight ratio and total protein concentration), apoptosis (Bax and Bcl2 protein), and histopathological alterations (intra-alveolar edema, alveolar hemorrhage, and neutrophil infiltration). Our results show that ischemia-reperfusion results in heightened inflammation, oxidative stress, apoptosis, lung edema, and histopathological damage. Quercetin showed preventive effects by reducing these markers, acting through modulation of the Nrf2/Keap1 pathway and inhibiting the NF-κB pathway. This anti-inflammatory effect, complementary to the antioxidant effects of quercetin, provides a multifaceted approach to cell protection that is important for developing therapeutic strategies against ischemia-reperfusion injury and could be helpful in preventive strategies against ischemia-reperfusion.
Authors
- Elham Madadizadeh (ORCID: https://orcid.org/0009-0002-4230-6510)
- Gholamreza Sepehri (ORCID: https://orcid.org/0000-0001-7999-9934)
- Elham Abbasloo (ORCID: https://orcid.org/0000-0002-3431-234X)
- Morteza Gholami (ORCID: https://orcid.org/0000-0003-0952-0654)
- Fatemeh Bejeshk
- Fatemeh Keshavarz (ORCID: https://orcid.org/0000-0003-2189-7809)
- Mohammad Abbas Bejeshk (ORCID: https://orcid.org/0000-0002-1372-1590)
- Farzaneh Zamiri Abdollahi (ORCID: https://orcid.org/0000-0002-9144-797X)
- Maryam Hossein Rezaei
- Fahimeh Rostamabadi (ORCID: https://orcid.org/0000-0003-4806-0208)
- Fatemeh Bagheri (ORCID: https://orcid.org/0000-0003-3484-4562)
- Mohammad Yousefi Zardak
- Mahla Jafaraghae
- Mahdiyeh Ranjbar Zeydabadi
- Meraj Baghgoli
- Ali Mahyaei
- Niyan Salehi
- Nasrin Soltani
- Fatemeh Sadat Moosavi
Institutions
- Shahid Bahonar University of Kerman (IR)
- Kerman University of Medical Sciences (IR)
- Iranian Legal Medicine Organization (IR)
- Bam University of Medical Sciences (IR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-10-04
- DOI
- https://doi.org/10.1038/s41598-024-73075-7
- Citations
- 28
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 16.04
Funders
- Kerman University of Medical Sciences